Article
Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.
Rheumatology (Oxford, England) - 1 Jan 2011
Iannaccone Christine K, Lee Yvonne C, Cui Jing, Frits Michelle L, Glass Roberta J, Plenge Robert M, Solomon Daniel H, Weinblatt Michael E, Shadick Nancy A
Abstract excerpt
The objective of this review is to report on the progress of the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study (BRASS) Registry data collection and summarize previous research in understanding therapeutic response to DMARDs using clinical and genetic data. The BRASS Registry, established in 2003, is a large, single-centre, prospective and observational cohort of 1100 RA patients. Patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.